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Abstract Saethre^Chotzen syndrome is an autosomal dominant
skull disorder resulting from premature fusion of coronal sutures
(craniosynostosis). It is caused by mutations in the TWIST gene
encoding a basic Helix^Loop^Helix transcription factor. Here
we report on the identification of a novel mutation affecting a
highly conserved residue of the basic domain. Unlike nonsense
and missense mutations lying within helices, this mutation does
not affect protein stability or heterodimerisation of TWIST with
its partner E12. However, it does abolish TWIST binding
capacity to a target E-box as efficiently as two missense
mutations in the loop^helix II junction. By contrast, elongation
of the loop through a 7 amino acid insertion appears not to
hamper binding to the DNA target. We conclude that loss of
TWIST protein function in Saethre^Chotzen patients can occur
at three different levels, namely protein stability, dimerisation,
and DNA binding and that the loop^helix II junction is essential
for effective protein^DNA interaction. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Saethre^Chotzen syndrome (SCS; MIM 101400) is an au-
tosomal dominant craniosynostosis syndrome characterised
by the premature fusion of coronal sutures leading to skull
deformation, accompanied by limb abnormalities of variable
severity and facial dysmorphism. This disorder has been as-
cribed to mutations in the human TWIST gene (H-TWIST)
which encodes a class B basic Helix^Loop^Helix (bHLH)
transcription factor [1,2]. Twist was ¢rst identi¢ed in Droso-
phila (D-Twist) as a zygotic developmental gene involved in
early mesoderm patterning [3,4]. Subsequently, several ortho-
logs of D-Twist have been identi¢ed in vertebrates: Xenopus
(X-Twist, [5]), mouse (M-Twist, [6]), and human (H-TWIST,
[7,8]), as well as a Twist-related factor in Caenorhabditis ele-
gans (Ce-Twist, [9]). Moreover, there is a high degree of ho-
mology in the bHLH domain; i.e. 84% amino acid identity
between Drosophila and vertebrates and 94^100% among ver-
tebrates. Twist does not seem to be critical for mesoderm
formation in vertebrates as Twist3/3 mice develop mesoderm
but die at embryonic day 11.5 [10]. However, Twist is required
for the proper regulation of muscle development in both in-
vertebrates [9,11] and vertebrates [12^15] suggesting that some
of its developmental functions and signalling pathways could
have been conserved during evolution.
The identi¢cation of mutations in H-TWIST as the under-
lying cause of SCS has uncovered a novel function for this
gene in the regulation of membranous bone ossi¢cation
[1,2,16]. So far, more than 50 di¡erent mutations scattered
over the coding sequence of H-TWIST have been reported
in SCS (for mutation update see [17]), most of which either
create premature termination codons or substitute highly con-
served residues in the bHLH region [18]. To date, however, no
obvious genotype^phenotype correlation has been observed in
SCS. Observations based on complete heterozygous deletions
of H-TWIST in some SCS patients and on the phenotype of
Twist+/3 mouse suggest haploinsu⁄ciency as the most likely
disease-causing mechanism [1,16,19]. In support of this, we
recently showed that amino acid changes in either helix I or
II result in mutant proteins that fail to dimerise with the class
A bHLH factor E12 (one of the two products of the E2A
gene, [20]) and become abnormally localised in the cytoplasm
[21]. By contrast, mutations altering the loop domain had
mild or no e¡ect on either protein dimerisation or its cellular
localisation. As patients harbouring TWIST mutations in ei-
ther helix or loop domains are clinically indistinguishable, we
hypothesised that mutations in the loop could result in hap-
loinsu⁄ciency via another molecular mechanism.
In this study, we tested the binding capacity of the TWIST/
E12 complex in several mutant proteins arising from either an
in frame insertion lying in the middle of the loop (P139ins7),
or two missense mutations in the loop^helix II junction
(S144R and K145E), or a novel mutation in the basic domain
of H-TWIST (R118C), to a target E-box. While R118C,
S144R and K145E mutant proteins displayed normal stability
and were able to shuttle to the nucleus as heterodimers with
E12, they failed to interact with the DNA binding site. By
contrast, the elongated protein resulting from the loop inser-
tion was still able to dimerise and bind the target E-box.
2. Materials and methods
2.1. DNA analysis
Blood samples were obtained with the written consent of the pa-
tients and genomic DNA was extracted from leukocytes according to
standard procedures. The whole coding sequence of the human
TWIST gene was ampli¢ed as previously described [18] and ampli¢-
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cation products were sequenced by using the £uorescent dideoxy ter-
minator method on an automatic sequencer ABI 373.
2.2. Expression vectors and in vitro protein^protein interaction assay
For eukaryotic expression in Cos7 cells and in vitro synthesis of
TWIST proteins, the whole coding sequence of TWIST was directly
PCR-ampli¢ed from genomic DNA of control and SCS patients using
the following primers: Twi-BamHI (forward) 5P-GACAGGATCCG-
GAGGAATGATGCAGGACGTGTCCAG-3P and Twi-SalI (reverse)
5P-GACTGTCGACCTAGTGGGACGCGGACATGG-3P. Mutant al-
leles were cloned into either the pCR3 unidirectional plasmid or the
pcDNA3.1/myc-His plasmid (Invitrogen, San Diego, CA, USA).
Clones were sequenced and con¢rmed to be free of errors. For in
vitro protein^protein interaction assays, wild-type, R118C, S144R,
K145E and P139ins7 TWIST cDNAs were transcribed and translated
from pCR3uni constructs using the TNT T7 MasterQuick transcrip-
tion/translation system (Promega, Madison, WI, USA) in the presence
of [35S]methionine (1000 Ci/mmol; Amersham Pharmacia Biotech,
UK). Glutathione S-transferase (GST)^E12 fusion proteins were pro-
duced in BL21 Escherichia coli cells transformed with the pGEX4T-1/
E12wt construct and interaction assays were performed as previously
described [21].
2.3. Cell culture, transfection and immuno£uorescence
Cos7 cells were seeded in either 6-well tissue culture plates or 8-well
chamber slides with 1.5U105 and 1U104 cells/well respectively, and
cultured to 70% con£uency. Transfections were performed with Fu-
gene-6 (Roche Molecular Biochemicals, Uppsala, Sweden) and 2 or
0.1 Wg DNA/well according to the manufacturer’s instructions. Trans-
fected cells in chamber slides were ¢xed 24 h later with 4% parafor-
maldehyde for 30 min. After permeabilisation with 0.1% Triton X-100
for 15 min, cells were incubated for 1 h at room temperature with a
goat polyclonal anti-TWIST antibody at dilution 1:100 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA). Cells were then incubated
with a £uorescein isothiocyanate (FITC)-conjugated donkey anti-
goat antibody and examined with a Zeiss LSM 510 confocal micro-
scope.
2.4. Electrophoretic mobility shift assays (EMSAs)
10 Wg of total Cos7 lysate were used per binding reaction (total
volume of 15 Wl) and incubated with a 32P-labelled synthetic dou-
ble-strand oligonucleotide containing a NdeI E-box adapted from
[22] (5P-CCCCCACCATATGGTGCCTGA-3P). Binding reactions
were carried out in a bu¡er containing 80 mM magnesium acetate,
200 ng/Wl poly dIdC, 1 Wg/Wl ssDNA, 10 mM NaH2PO4/Na2HPO4,
1 mM EDTA, pH 7.2, incubated on ice for 15 min and samples were
then electrophoresed at room temperature on native 5% polyacryl-
amide/0.5UTBE gels. For supershift assays, 5^10 Wg anti-E12 (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) or anti-Myc antibodies
(Roche Molecular Biochemicals, Uppsala, Sweden) were added to the
binding reaction. Gels were ¢xed for 15 min in 10% acetic acid/10%
methanol solution, dried under vacuum for 45 min and exposed to
¢lms (Biomax RM, Eastman Kodak Company, Rochester, NY, USA)
in the dark at 380‡C for time periods between 6 h and 2 days.
Fig. 1. Location of four SCS mutations a¡ecting the bHLH domain of the TWIST protein. A: Schematic representation of the human TWIST
protein showing positions of the R118C, P139ins7 (in frame duplication of KIIPTLP), S144R and K145E mutations in the basic domain, the
middle of the loop, the end of the loop and the start of helix II, respectively. B: Multiple sequence alignments of the bHLH region from di¡er-
ent Twist orthologs ((H), Human; (M), Mouse; (X), Xenopus ; (D), Drosophila ; (Ce), C. elegans) and from Dermo-1, MyoD and E12. Sequen-
ces were aligned using the CLUSTAL-W program [35]. Conserved residues are shown on a black background and mentioned in the consensus
sequence. Note that two mutant residues (arginine 118 and lysine 145, underlined in the consensus sequence) are highly conserved through evo-
lution.
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3. Results
3.1. Identi¢cation of a novel SCS mutation in the basic domain
of H-TWIST
Clinical and radiological examination of a man and his two
a¡ected sons revealed typical features of SCS, namely, unilat-
eral or bilateral coronal suture fusion, small ears with crura
and low frontal hair line. Direct sequence analysis of the
coding region of TWIST revealed a C to G transition at
position 352 segregating with the disease and causing an argi-
nine to cysteine substitution in the basic domain (R118C). The
location of this amino acid change and that of three previ-
ously reported mutations [18] a¡ecting the centre of the loop
(P139ins7) and the loop^helix II junction (S144R, K145E) are
presented in Fig. 1A. Alignment of bHLH amino acid sequen-
ces from other transcription factors revealed that arginine 118
and lysine 145 are highly conserved both across species and
among members of the bHLH transcription factor family,
while serine 144 is less conserved (Fig. 1B).
3.2. Expression, dimer formation and intracellular localisation
of basic and loop mutant proteins
To determine how mutations of the basic and loop domains
alter protein function in SCS, human TWIST cDNAs carry-
ing the R118C, the S144R, the K145E or the P139ins7 geno-
types were cloned in an expression vector, translated in vitro
in a reticulocyte lysate system and found to result in molecules
of the expected size (data not shown). RNA and protein
stability was then tested by ectopically expressing wild-type
and mutant constructs in transfected Cos7 cells. Northern
blot and immunoblot analyses of cell lysates showed that,
24 or 48 h post-transfection, the amount of mutant transcripts
and proteins were similar to controls, suggesting that mRNA
and protein stability remained unaltered (not shown).
The mutant proteins were still able to interact with E12
fused to GST (GST^E12), as shown by the binding of in-
vitro-translated TWIST proteins to the GST^E12 fusion pro-
tein (Fig. 2A). Additional evidence of these interactions stems
from yeast two-hybrid assays that revealed normal heterodi-
merisation of the three missense mutants and reduced hetero-
dimerisation of the loop insertion (data not shown, [21]). We
conclude that mutations altering either the basic domain or
the loop^helix II junction of TWIST do not a¡ect the dimer-
isation capacities of the protein. Mutant proteins were then
co-expressed with E12 in Cos7 cells and their localisation was
analysed by confocal immuno£uorescence microscopy. Cells
transfected with the R118C, S144R or K145E mutant con-
structs exhibited a strong nuclear staining with anti-TWIST
antibodies in a pattern similar to wild-type transfected cells
(Fig. 2B^D). Transfection with the P139ins7 mutant induced
preferential nuclear localisation but cytoplasmic staining was
detected in 30% of transfected cells (Fig. 2E).
3.3. Binding of wild-type TWIST proteins to a DNA sequence
speci¢c of the human TWIST/E12 heterodimers
Based on functional data obtained in invertebrates [9,11],
and more recently in mouse [23], a putative Twist binding site
has been identi¢ed. We therefore designed a double-stranded
DNA probe containing an hexanucleotide motif CATATG
(NdeI E-box) for assaying the binding capacities of the human
protein. EMSAs were performed using lysates from Cos7 cells
expressing H-TWIST, E12 or both proteins. We found that
H-TWIST was able to bind the NdeI E-box, only when co-
expressed with E12 in transfected cells (Fig. 3A, lane 5). The
speci¢city of binding was demonstrated by using: (i) variable
amounts of unlabelled probe (Fig. 3A, lanes 6 and 7) that
competed with the labelled probe, and, (ii) human anti-E12
antibodies that produced a supershift of the DNA^protein
complex (Fig. 3A, lane 8). Since antibodies raised against
the amino-terminal domain of H-TWIST gave only a weak
supershift (not shown) that could be ascribed to the low af-
¢nity of the antibody, we generated a myc-tagged TWIST
cDNA construct (mtTwi) for co-transfection with E12. Incu-
bation of the cell lysate with an anti-myc antibody resulted in
Fig. 2. Dimerisation capacities and subcellular location of wild-type
and mutant TWIST proteins. A: In vitro interaction between 35S-la-
belled wild-type TWIST and GST^E12 (lane 1) was not a¡ected by
the R118C, K145E, S144R or P139ins7 mutations (lanes 3, 5, 7 and
9, respectively). As expected, no interaction occurred between
TWIST proteins and GST alone (lanes 2, 4, 6, 8 and 10). Half the
amount of radiolabelled TWIST protein used for the assay is shown
as an input. B^D: Subcellular immunolocalisation of the wild-type
and mutant TWIST proteins in Cos7 cells co-transfected with E12.
Mutant proteins in the basic domain (C) and the loop^helix II junc-
tion (D) disclosed the same nuclear staining as the control (B). In-
sertion in the loop induced both cytoplasmic and nuclear localisa-
tion of the elongated protein (E).
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a supershift of the DNA^protein complex (Fig. 3A, lane 10).
Similarly, incubation of the TWIST/E12 complex with a
CAGCTG motif (PvuII E-box) known to give no bandshift
with the D-Twist protein [11], also failed to produce a band-
shift (not shown). Hence, the human TWIST/E12 complex is
able to bind the NdeI probe and to speci¢cally recognise the
CATATG motif. In addition, in vivo heterodimerisation of
the TWIST protein with E12 in co-transfected cells appears
Fig. 3. Absence of TWIST/E12 DNA binding in R118C, S144R and K145E TWIST mutants. A: EMSA of the human TWIST protein to the
NdeI E-box. Total lysates from untransfected (lane 2) or transfected Cos7 cells (lanes 3^10) were incubated with the radiolabelled probe (6000
cpm). Transfection with either wild-type (wt) TWIST or E12 cDNA constructs gave no speci¢c bandshift (lanes 3 and 4), while co-transfection
with TWIST and E12 gave a speci¢c shift (lanes 5 and 9). Unlabelled probe (0.5 and 1.0 nmol) was used to compete for the binding (lanes 6
and 7, respectively). Speci¢city of the TWIST/E12 complex was assessed by using antibodies against either E12 (lane 8) or myc-tagged TWIST
(lane 10). B: EMSA of the wild-type (wt) and mutant TWIST proteins to the NdeI E-box (6000 cpm). TWIST/E12 DNA binding (lane 2) is
abolished when the R118C, K145E or S144R missense mutations are introduced (lanes 3, 4 and 5, respectively), but persists with the P139ins7
mutation (lane 6). C: EMSA of the wild-type (wt) and mutant TWIST proteins (R118C and K145E) to the NdeI E-box using decreasing
amounts of the radiolabelled probe, ranging from 260 000 to 1000 cpm (lanes 1^6, 7^12 and 13^18). N.S. = non speci¢c signal, Ab = antibody,
mt = myc-tag.
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to be required for e⁄cient binding to the CATATG motif, as
in vitro co-incubation of cell lysates derived from Cos7 cells
separately transfected with either TWIST or E12 resulted only
in a weak bandshift (not shown).
3.4. Mutations in the basic domain and the loop^helix II
junction abolish TWIST DNA binding activity
The normal stability of basic, loop and loop^helix II mu-
tant proteins and their capacity to form heterodimers led us to
hypothesise that in these cases, the loss of TWIST function
could result from an impairment of protein^DNA interaction.
Therefore, we performed EMSA by using the NdeI E-box as a
probe and Cos7 lysates expressing E12 and R118C, S144R,
K145E or P139ins7 TWIST mutant proteins. Both basic and
loop^helix II junction missense mutations induced a loss of
the TWIST/E12 DNA binding activity, while insertion in the
loop did not hamper the binding (Fig. 3B). To test whether
the absence of bandshift resulted from a complete loss of the
binding activity or a decreased a⁄nity of the mutated complex
for the probe, we repeated the experiment using variable
amounts of radiolabelled NdeI probe. Fig. 3C shows that
both R118C and K145E TWIST/E12 complexes failed to
give a bandshift even when high amounts of probe were
used, indicating that both mutations abolished TWIST^
DNA binding activity. Similar results were obtained with
the S144R mutant protein (not shown).
4. Discussion
Although SCS mutations commonly involve the bHLH re-
gion of H-TWIST [17,18], the resulting alteration in gene
function depends on the particular protein subdomain af-
fected. Nonsense mutations upstream or within the bHLH
motif cause the synthesis of truncated proteins which are rap-
idly degraded [21], while missense mutations involving helix I
or II region create proteins that fail to heterodimerise and
become abnormally located in the cytoplasm [21]. Surpris-
ingly, missense mutations in the loop^helix II junction of
the bHLH motif a¡ect neither protein stability nor the ability
to form heterodimers. Hence, the goal of the present study
was to explore alternative mechanism(s) by which mutations
in the basic or loop domains of TWIST alter protein function
in SCS. Using an assay that relies on the high binding a⁄nity
of the TWIST/E12 heterodimer for the NdeI E-box, we show
here that unlike in frame insertion in the loop, missense mu-
tations in either the basic domain or the loop^helix II junction
of H-TWIST yield proteins that lack NdeI E-box binding
capacity. Our results therefore identify a novel mechanism
by which a Twist mutation can result in haploinsu⁄ciency
in SCS (Table 1).
bHLH transcription factors are known to bind DNA mo-
tives consisting of hexanucleotide sequences CANNTG called
E-boxes [24], located in the promoter and enhancer regions of
target genes. One such cluster termed NdeI E-box, which is
known to interact with D-Twist, has been found in the up-
stream region of the NK-4/Tinman homeobox gene [11]. Two
such palindromic motives have also been found in a 22-bp
enhancer element of the ceh-24 gene which encodes a C. ele-
gans NK-2 homeodomain transcription factor [9] and re-
cently, Kophengnavong et al. showed that this same NdeI
E-box can bind M-Twist, although no target gene has yet
been identi¢ed in mouse [23]. In their in vitro assays, M-
Twist/E12 heterodimers bound DNA more e⁄ciently than
M-Twist alone or E12 homodimers. These observations di¡er
from ours, however, in that we could not detect any bandshift
for human TWIST in the absence of E12. Moreover, we
found that E12 homodimers were also unable to bind the
CATATG motif, further supporting the hypothesis that het-
erodimerisation of H-TWIST with E12 in vivo is essential for
transcriptional activity of human TWIST.
The loss of interaction between the basic domain and the
CATATG motif as a mechanism can be further explored by
three-dimensional analysis of the complex formed between
TWIST protein and DNA. Because the crystal structure of
TWIST protein is still unsolved, we used MyoD dimer com-
plexed with DNA as a model [25]. This would be valid for two
reasons. First, there is a high degree of conservation between
TWIST arg118 and lys145 on one hand, and MyoD arg119
and lys146 on the other (Figs. 1 and 4). Second, the fold
region of di¡erent bHLH proteins also appears to be highly
conserved, as is the case for example between MyoD, E47
(another bHLH product of the E2A gene) and Max1 (a
bHLH-zipper transcription factor) [25^27]. Although MyoD
and Twist possess di¡erent bp at the centre of their CANNTG
consensus binding sites (GC for MyoD and TA for Twist),
crystallographic analyses of MyoD and E47 complex have
shown that these bases do not directly contact the amino acids
of the basic region [25,26]. This suggests that these central
bases most likely play a role in functional speci¢city through
di¡erences in the conformation of the basic region/DNA com-
plex. Interestingly, replacement of arginine 119 by a cysteine
residue in the MyoD/DNA model abolishes the hydrogen
bond that normally exists between the arginine side chain
and phosphates of the diester backbone forming the E-box
(Fig. 4C,D), further emphasising the requirement for an argi-
nine at that position. It is thus tempting to speculate that
replacement of TWIST arginine 118 by a cysteine would sim-
ilarly disrupt the interaction with the phosphodiester back-
bone and account for our results. Of particular interest is
the observation that in the loop^helix II junction of MyoD,
lysine 146 (equivalent to lysine 145 in H-TWIST) is located in
the vicinity of the DNA strand (Fig. 4A,B). This lysine do-
nates a hydrogen bond to the phosphate group of adenine
forming the E-box through its side chain [25]. Similar conclu-
sions have been drawn from the E47/DNA crystal structure
[26]. In the case of Twist, substitution of lysine 145 by
Table 1






Nonsense 3 3 3 3
Missense
Basic (B) + + + 3
Helix I (H) + 3 3 3
Loop^helix II
Junction (LH II) + + + 3
Helix II (H) + 3 3 3
TWIST nonsense and missense mutations alter gene function in dif-
ferent ways: (i) nonsense mutation a¡ect protein stability, (ii) mis-
sense mutations in helices (H) hamper heterodimerisation with E12
and nuclear location, (iii) missense mutations in the basic domain
(B) or at the loop^helix II junction (LH II) abolish DNA binding
to the NdeI E-box. A¡ected or una¡ected functions are marked
with (3) or (+) signs respectively.
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glutamic acid (mutation K145E) would prevent hydrogen
bond formation between the phosphate group and the lateral
chain, thus providing an explanation for the critical role of
lysine in DNA binding. Similarly, a K145N missense mutation
[28] is also likely to hamper DNA binding.
Remarkably, serine 144, the last residue of the loop in
TWIST also appears to be involved in bHLH^DNA interac-
tion as mutation to arginine eliminates TWIST binding ca-
pacities. Conservation of this amino acid among bHLH pro-
teins is less remarkable than lysine 145, although it is present
in more than 30% of hitherto identi¢ed bHLH transcription
factors [29]. We suggest therefore, that conversion of serine
into arginine may induce steric hindrance due to the bulky
lateral chain of arginine and impair anchoring of the loop^
helix II junction to DNA. Besides, persistence of DNA bind-
ing of the P139ins7 mutant despite loop elongation further
indicates that the size of the loop plays a less critical role
than the loop^helix II junction for protein^DNA interaction.
The mechanism by which the P139ins7 genotype is converted
into SCS phenotype remains unclear although reduced heter-
Fig. 4. Three-dimensional interpretation of the consequences of the TWIST R118C mutation on the protein^DNA complex using the MyoD^
DNA interaction model. A: Stereodiagram of a MyoD^DNA complex drawn from [24] showing interaction between DNA (in red, yellow and
white) and the basic regions of two MyoD monomers (in red, blue and white). Mutated amino acids, equivalent to arg118 and lys145 in the
H-TWIST protein, are indicated by arrows. B: Sketch of the protein^DNA complex in the same orientation as in A. The 14-bp DNA site is re-
presented as yellow and red ribbons. The K-helices (I and II) of the bHLH domain are represented in dark blue and the basic regions are in light
blue. Location of mutated amino acids is shown by arrows. C: Higher magni¢cation of the inset in A showing the presence of an hydrogen
bond (dotted green line) between the lateral chain of arginine 119 (in white and blue) and a phosphate residue (in yellow and red) of the sugar-
phosphate DNA backbone. D: Disruption of protein^DNA interaction caused by substitution of arginine 119 by a cysteine residue. The cysteine
lateral chain is unable to form an hydrogen bond with a phosphate residue of the DNA backbone. Colour coding is as follows: white, carbon
atoms; red, oxygen atoms; blue, nitrogen atoms; yellow, phosphorus atoms. The Swiss-PdbViewer program (v3.51) from GlaxoWellcome Exper-
imental Research was used to visualise the putative e¡ect of the R119C mutation on the murine MyoD crystal structure (Swiss-Prot accession
number for mouse MyoD: P10085, Protein Data Bank Id: 1MDY).
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odimerisation with E12 and partial mis-localisation of the
protein are likely to be involved.
Three other missense mutations in the basic domain of
H-TWIST have been reported so far in SCS [17], two of which
alter highly conserved residues involved in the formation of
hydrogen bonds between phosphates and amino acid lateral
chains (R116W and R120P). Based on the MyoD model, we
would predict that they hamper binding to the NdeI E-box in
a manner similar to the R118C mutation reported here. By
contrast, the third mutation (Q119P) substitutes a residue
which is conserved among Twist proteins across di¡erent spe-
cies but to a lesser extent among other bHLH proteins (19%
according to [29]), suggesting that glutamine might be in-
volved in the functional speci¢city of the Twist basic domain.
The high degree of conservation between Twist bHLH mo-
tif and its target DNA sequence across species suggests, but
does not prove, common target genes. Analysis in inverte-
brates suggests a direct link between Twist and genes encoding
¢broblast growth factor receptors genes (Fgfr). This hypoth-
esis is based on (i) the physical interaction of Ce-Twist with
the promoter of egl-15 (an Fgfr homologue) in C. elegans [9]
and, (ii) the requirement of D-Twist for expression of DFR-1
(one of the two Fgfr homologues) in Drosophila [30]. Consid-
ering that mutations in H-TWIST and FGFR1-3 genes ac-
count for phenotypically related human craniosynostoses
[31] and that pattern of Fgfr gene expression is altered in
the sutures of heterozygous M-Twist-null mice [32], one can
hypothesise that a direct relationship also exists between Fgfrs
and Twist in vertebrates [32,33]. This remains as a specula-
tion, however, since we could not detect any NdeI E-box in a
3-kb sequence spanning human FGFR2 and FGFR3 promoter
regions (unpublished observations).
Heterozygous deletions of the H-TWIST gene are the most
direct evidence for haploinsu⁄ciency in SCS [19]. Likewise,
defective transcriptional regulation of H-TWIST through a
positional e¡ect has been evoked as another mechanism that
could account for the disease [34]. From our results (this study
and [21]), we conclude that mutations in the H-TWIST gene
can cause skeletal abnormalities by three other mechanisms,
all of which result in a loss of function of the TWIST protein.
These are: (i) protein instability, (ii) loss of dimerisation lead-
ing to abnormal cellular localisation and (iii) loss of DNA
binding activity. SCS thus represents an original genetic mod-
el for analysing the critical functions of di¡erent subdomains
in bHLH proteins.
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